All Articles

A new report reveals 632 cancer antibody deals since 2016. We analyze the multi-billion-dollar partnerships driving the next wave of cancer therapy.

Facing steep revenue decline from customer churn, Boardwalktech bets on aggressive cost cuts and an AI-powered platform pivot to survive. Is it enough?

Brookfield's latest preferred share issue is more than a simple refinance; it's a strategic move to cut long-term costs and fuel its global empire.

A new partnership with a Vietnamese agri-giant reveals Del Monte’s strategy to combat disease, climate change, and secure the future of our fruit supply.

Pharma firm SciSparc is betting big on a GERD device, but can it navigate global markets and shareholder dilution for a slice of a $3 billion industry?

Struggling automaker Chijet Motor's new $400M digital treasury dwarfs its market cap, signaling a risky pivot that redefines its entire corporate identity.

A Canadian miner’s upgrade to the OTCQX market is more than a financial move; it’s a key step to funding Mongolia’s next wave of essential tech metals.

Successful long-term toxicology data for HER-096 builds on Phase 1b success, solidifying its path to a pivotal Phase 2 trial for Parkinson's disease.

A new burger joint in Oregon seems unrelated to medicine, but its data-driven expansion and customer tech offer a playbook for AI innovation in healthcare.

Primior launches its GAIA tokenization platform, aiming to open institutional U.S. real estate to global investors amid growing regulatory clarity.

A NYC limo service is weaponizing child safety to outmaneuver Uber and Lyft. It's a strategic play in a market where peace of mind is the ultimate luxury.

Following pressure from activist Engine Capital, Civeo adds two new directors. Can they steer the hospitality giant toward renewed growth and profit?

As demographics shift, advocates push for innovative community care models and independent oversight to support Ontario's rapidly aging population.

A new report reveals over 500 diagnostic deals are reshaping medicine. We decode the strategy, the players, and what it means for the future of patient care.

A top Czech bank's deal with Camunda is more than a tech upgrade; it's a blueprint for efficiency that could reshape Central Europe's financial landscape.

FDA's nod for Otsuka's first-in-class IgAN drug ushers in a new era of targeted therapy, but the real test of its long-term promise is yet to come.

Stronger than steel and fully biodegradable, nanocellulose is set for explosive growth. Discover the eco-material reshaping everything from packaging to medicine.

Five attorneys from one firm were named Fort Worth's best. We look beyond the awards to see how a unique strategy cultivates elite legal talent.

A new venture pioneers Tesla's business program, blending high-speed charging with lifestyle hubs. Is Suncoast Charging's model the future of EV networks?

DRYWORLD, a small-cap apparel brand, enters the crowded running shoe market with its innovative Phoenix RUN. A bold leap or a stumble in the making?